Mumbai: In a move to strengthen its position in the topical pain relief segment, Mankind Pharma, India’s fourth-largest pharmaceutical company, has announced the appointment of Rajkummar Rao as the brand ambassador for its flagship offering, Nimulid Strong Pain Relief Gel & Spray. With its powerful 2X Diclofenac formulation, Nimulid Strong is positioned as the “Neck Pain Specialist”, delivering rapid relief in just two minutes.
The partnership aligns the brand’s promise of effective, localized relief with Rao’s grounded and relatable persona, making him an ideal fit to champion Nimulid Strong’s mission.
“We’re absolutely thrilled to welcome Rajkummar Rao to the Mankind Pharma family, representing Nimulid Strong,” said Joy Chatterjee, Vice President, Sales and Marketing Head, Consumer Business Unit, Mankind Pharma. “Rajkummar’s authenticity, relatability, and incredible craft resonate deeply with our audience, making him the ideal choice to represent Nimulid Strong – ‘The Neck Pain Specialist.’ Our mission is to empower individuals to overcome these challenges and lead pain-free lives, and with Nimulid Strong, they can experience relief in as little as 2 minutes.”
Known for his acclaimed performances in Stree, Srikanth, and Bareilly Ki Barfi, Rajkummar Rao shared his excitement about the collaboration, “As an actor, I understand the importance of being able to perform at your best, and pain can really get in the way of that. Nimulid Strong’s promise of 2-minute relief for neck pain is a game-changer. It’s a product that truly resonates with the everyday struggles we face, whether from long hours, screen time, or just daily stress. I’m excited to be a part of the Mankind Pharma family and to endorse a brand like Nimulid Strong that offers such effective and quick relief, helping people get back to their lives without pain holding them back.”
With over ₹15 crore in sales and approximately 30 lakh units sold in its first year, Nimulid Strong has made a strong debut in a topical pain relief market valued at ₹5,000 crore. Unlike most competitors that use 1.16% Diclofenac concentration, Nimulid Strong features a potent 2.32% formulation, delivering faster and deeper relief from neck pain, stiffness, and inflammation.
Available in gel and spray formats, Nimulid Strong offers long-lasting and on-the-go solutions tailored for today’s digitally fatigued and posture-stressed generation. With plans to expand the product line to include balms, roll-ons, and tablets, Mankind Pharma is eyeing category leadership with a strong focus on innovation and accessibility.
This collaboration also highlights Mankind Pharma’s larger commitment to addressing modern pain challenges such as tech neck, work-from-home strain, and sedentary fatigue, helping consumers return to their routines without disruption.
